Hong Kong Putai Medical Technology Co. Limited

Computational simulation of drug molecule pharmacology:
Our company provides solutions in computational simulation of drug molecule pharmacology. By simulating the interactions between molecules and targets, we can predict the binding modes, affinity, and inhibitory activity of drug molecules. This aids in expediting the drug development process, optimising candidate drug structures, and forecasting their pharmacological effects within the human body.

AI-based drug screening and design:
We have developed AI-powered tools for drug screening and design. Through the analysis of vast amounts of compound data and pharmacological information, we leverage machine learning and data mining techniques to establish prediction models and algorithms for swift screening of potential drug candidates and the design of novel drug molecules. This AI-based approach accelerates the drug discovery process and enhances research and development efficiency.

Prediction of drug molecule crystal forms:
Our team is also dedicated to predicting the crystal forms of drug molecules. Through computational simulations and crystallographic analysis, we can predict the crystalline forms and crystal structures of drug molecules in the solid state. This is crucial for drug stability, bioavailability, and the development of drug formulations. Our crystal form prediction technology assist researchers in optimising the physical properties of drugs and guides the design of drug formulations and manufacturing processes.